Clear Street Markets LLC Moderna, Inc. Transaction History

Clear Street Markets LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$101.21 - $166.61 $5,161 - $8,497	51 New	51 $6,000
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $70,344 - $105,683	-1,012 Reduced 97.03%	31 $3,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $46,469 - $61,026	482 Added 85.92%	1,043 $108,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $66,478 - $90,057	561 New	561 $68,000
Q3 2022 Nov 02, 2022	BUY	$118.07 - $194.18 $171,909 - $282,726	1,456 New	1,456 $172,000
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $210,951 - $318,038	-1,801 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $227,754 - $423,325	1,801 New	1,801 $310,000
Q1 2021 Apr 14, 2021	SELL	$109.18 - $185.98 $1.33 Million - $2.27 Million	-12,200 Closed	0 $0
Q4 2020 Feb 25, 2021	BUY	$65.74 - $169.86 $802,027 - $2.07 Million	12,200 New	12,200 $1.27 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.